The QualityStocks Daily Tuesday, January 14th, 2020

Today's Top 3 Investment Newsletters

StreetInsider (RTIX) +63.41%

MarketClub Analysis (INPX) +54.79%

QualityStocks (GTHP) +34.99%

The QualityStocks Daily Stock List

Acacia Pharma Group plc (ACPGF)

The Hot Penny Stocks, Stocks Café, OTC Markets, Speculating Stocks, Investor Point, Macroaxis, Current Charts, InvestorsHub, Investors Hangout, and Stockhouse reported earlier on Acacia Pharma Group plc (ACPGF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Acacia Pharma Group plc is a hospital pharmaceutical group listed on the OTC Markets. The Company focuses on the development and commercialization of new nausea and vomiting treatments for surgical and cancer patients. Acacia Pharma has developed a late-stage pipeline of hospital nausea and vomiting product candidates based on repurposing existing drugs in new therapeutic indications. Its product candidates are differentiated from the original marketed drug by using a different delivery method and/or dose that is suitable for its new medical use. Acacia Pharma Group is headquartered in Cambridge, the United Kingdom (UK).

The Group has discovered two product candidates based on the same active ingredient, amisulpride. BARHEMSYS® (formerly APD421) is an intravenous formulation of amisulpride, a selective dopamine antagonist that has completed Phase 3 clinical development for the prophylaxis and treatment of post-operative nausea & vomiting (PONV), alone and in combination with other antiemetics.

APD403 is based on the selective dopamine antagonist amisulpride, the same active ingredient as in BARHEMSYS®. It is undergoing development as an intravenous injection for cancer patients to be administered immediately before they receive chemotherapy to prevent acute chemotherapy-induced nausea & vomiting (CINV), and as an oral tablet to prevent delayed CINV.

In September 2019, Acacia Pharma Group announced that the US Food and Drug Administration (FDA) accepted the Group’s resubmitted New Drug Application (NDA) for BARHEMSYS® (amisulpride injection). The FDA has classified the resubmission as Class 2 and has given a Prescription Drug User Fee Act (PDUFA) goal of reviewing and acting on it no later than February 26, 2020.

Last week, Acacia Pharma Group announced it entered into a strategic in-licensing transaction with Cosmo Pharmaceuticals N.V. (SIX: COPN). This transaction grants to the Group exclusive US commercialization rights to ByFavo™ (remimazolam). It has been made alongside an equity investment and debt facility by Cosmo Pharmaceuticals to finance the marketing efforts of BARHEMSYS® and ByFavo™.

ByFavo™ is an ultra-short-acting and reversible intravenous sedative/anaesthetic. A New Drug Application (NDA) is now under review by the FDA. The target review (PDUFA) date is April 5, 2020.

Acacia Pharma Group plc (ACPGF), closed Tuesday's trading session at $3.33, even for the day, on 2,000 volume. The average volume for the last 3 months is 250 and the stock's 52-week low/high is $2.45000004/$3.32999992.

chart

Better Choice Company, Inc. (BTTR)

TipRanks, Investor Place, Market Wire News, Street Insider, National Institute for Cannabis Investors, All Cap Research, TeleTrader, Market Screener, OTC.Watch, Stockwatch, TradingView, Simply Wall St, and Wallet Investor reported beforehand on Better Choice Company, Inc. (BTTR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Better Choice Company, Inc. is an animal health and wellness CBD (cannabidiol) company listed On the OTC Markets’ OTCQB. It has acquired TruPet LLC and Bona Vida, Inc. Better Choice Company offers consumers a carefully curated collection of first-class pet brands, hemp-derived CBD supplements, and other services that support pet wellness. The Company is based in New York, New York.

Better Choice’s vision is to provide clean, holistic, and nutritional options for consumers who want to bring their own healthier lifestyle to their pets. The Company’s products promote wellness and support better and longer lives for pets. Better Choice’s TruPet is an online seller of ultra-premium, all-natural pet food, treats and supplements. TruPet has a special emphasis on freeze dried and dehydrated raw products.

Bona Vida is a unique emerging CBD platform. Bona Vida’s focus is on developing a portfolio of brand and product verticals within the animal and human health and wellness space.

Better Choice’s portfolio includes TruDog, an online seller of ultra-premium, freeze-dried raw pet food, treats and supplements, and Elvis Presley’s Hound Dog, an inventive CBD platform. In addition, its portfolio includes TruGold, a hemp-based product line, and Rawgo!, a premium dehydrated dog food. The Company’s portfolio also includes Orapup, a dental health system for dogs, TruCat, a premium pet food and supplements brand for cats, and Pet Premium, a foremost pet insurance provider.

Better Choice Company has a strategic partnership with Authentic Brands Group (ABG). ABG (New York, New York) is a worldwide brand development, marketing, and entertainment company and owner of Elvis Presley Enterprises LLC. This strategic partnership is for a line of CBD pet products under the Elvis Presley Hound Dog brand.

Recently, Better Choice Company provided shareholders with a financial update of its earlier announced acquisition of holistic pet foods leader Halo, Purely for Pets® (Halo®). On an annualized basis, Halo is presently generating Net Sales of about $33.4 million. This is based on Better Choice Company’s unaudited fiscal year-to-date results (July 1, 2019 to November 30, 2019), which Net Sales is roughly $13.9 million. Halo® focuses on the quality of its pet nutrition products using OrigiNative™ GAP and MSC-certified proteins that say no to factory farming and offer Superior Digestibility.

Better Choice Company, Inc. (BTTR), closed Tuesday's trading session at $2.15, off by 12.2449%, on 4,601 volume with 22 trades. The average volume for the last 3 months is 11,822 and the stock's 52-week low/high is $1.30999994/$11.3100004.

chart

Bionik Laboratories Corp. (BNKL)

Zacks, Proactive Investors, Barchart, Business Wire, Stockhouse, Wallet Investor, last10k, The Street, Seeking Alpha, Research and Markets, MarketWatch, Stockopedia, InvestorsHub, Corporate Information, PR Newswire, and OTC Markets reported beforehand on Bionik Laboratories Corp. (BNKL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Bionik Laboratories Corp. concentrates on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home. A robotics company, it has three products on the market and four products in different stages of development. These products are centered on upper and lower extremity rehabilitation for stroke and other mobility-impaired patients. OTCQB-listed, Bionik Laboratories is based in Toronto, Ontario and has its U.S. headquarters in Watertown, Massachusetts.

The Company’s family of robotic rehabilitation products are the result of ground-breaking medical engineering research and development (R&D) at the Newman Laboratory for Biomechanics and Human Rehabilitation at the Massachusetts Institute of Technology (MIT). Bionik’s products include InMotion ARM ™; InMotion HAND™, and InMotion WRIST™.

InMotionRobots™ are for all stages of recovery – from acute to chronic. Bionik Laboratories has its newest generation InMotion ARM/HAND™ robotic system for clinical rehabilitation of stroke survivors and those with mobility impairments because of neurological conditions.

The design of the Company’s modular systems approach to neurorehabilitation is to optimize the use of robotics in a manner consistent with the most modern clinical research and neuroscience. This is while considering the latest understanding on motor learning interference and motor memory consolidation.

Bionik’s robotic products have excellent capacity for measurement and immediate interactive response. These products sense the patient’s movement and respond to a patient’s continually-changing ability. Furthermore, robots guide the exercise treatment accordingly and provide quantifiable feedback on progress and performance. Additionally, if the patient cannot move, the robot gently assists the patient to initiate movement towards the target.

Recently, Bionik Laboratories announced it chose Propel, the product success platform built on Salesforce, to be its Product Lifecycle Management and Quality Management System solutions provider to speed up new product development and manufacturing of InMotion™ products and services. Propel offers an integrated solution that inventively combines next-generation Product Lifecycle Management (PLM) and Quality Management System (QMS) on a single platform.

Bionik Laboratories expects that Propel will help extend the definition of product success from concept to customer through configuring and deploying a secure, flexible, and compliant platform designed to enhance the delivery of Bionik’s key offerings, for example its InMotion™ robotic devices and InMotion Connect™ software platform.

Bionik Laboratories Corp. (BNKL), closed Tuesday's trading session at $1.55, off by 3.125%, on 150 volume with 2 trades. The average volume for the last 3 months is 206 and the stock's 52-week low/high is $1.00999999/$100.00.

chart

Braveheart Resources, Inc. (RIINF)

Zacks, The Gold Telegraph, Stock Pulse, Junior Mining Network, Gold Stock Data, The Prospector News, Morningstar, Mining and Energy, Proactive Investors, Stockhouse, 4-Traders, Seeking Alpha, TradingView, Investors Hangout, Simply Wall St, and Nasdaq reported previously on Braveheart Resources, Inc. (RIINF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Braveheart Resources, Inc. is a junior mining company centered on building shareholder value through exploration and development in the favourable and proven mining jurisdictions of the East and West Kootenays of British Columbia. It explores for gold, copper, and silver deposits. The Company previously went by the name Rainbow Resources, Inc. It changed its name to Braveheart Resources, Inc. in November of 2014. OTCQB-listed, Braveheart Resources is headquartered in Calgary, Alberta.

The Company's principal asset is the Bull River Mine project that has a current mineral resource containing copper, gold and silver. This property is fully developed with 21,000 meters of underground developments in terms of ramps, raises and drifting on mineralized structures on seven levels.

The surface infrastructure at the Bull River Mine project includes a 750 tonne per day conventional mill with adjoining crushing facilities and offices and mine maintenance facilities. The property is connected to grid power; there is year-round access to the site by paved and all-weather roads.

The Bull River Project has an Indicated Resource of 1.51 M tonnes @ 2.263 % Cu Eq. It has an Inferred Resource of 0.34 M tonnes @1.86% Cu Eq. The Project has a large land package including a number of past producers - 9,800 hectares. There is the potential to recover cobalt in a pyrite/cobalt concentrate. The Property is 100 percent owned by Braveheart Resources.

Braveheart Resources is also pursuing the development of its Alpine Mine property near Nelson, British Columbia. This is a past producing, high grade, underground gold mine. Braveheart’s intention is to truck the Alpine ore to the newly acquired Bull River Mill located in Cranbrook, British Columbia.

Last week, Braveheart Resources announced that it plans to commence drilling from underground workings at the Bull River Mine project. The purpose of the drilling program will be to test the down dip extension of the vein systems under the present workings. Roughly 3,000 meters of drilling is planned for Q1 of 2020. At present, Braveheart, is completing ground support activities at the proposed drill locations.

Braveheart Resources, Inc. (RIINF), closed Tuesday's trading session at $0.097, even for the day, on 25,000 volume. The average volume for the last 3 months is 622 and the stock's 52-week low/high is $0.071170002/$0.141599997.

chart

H/Cell Energy Corporation (HCCC)

Uptick Newswire, Fairly Valued, MarketBeat, Financial Buzz, OTC Markets, Street Insider, 4-Traders, Stockwatch, Stockopedia, Market Screener, Simply Wall St, Stockhouse, Wallet Investor, Morningstar and Equities reported earlier on H/Cell Energy Corporation (HCCC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

H/Cell Energy Corporation designs and implements clean energy solutions featuring hydrogen and fuel cell technology. The Company is an integrator that concentrates on the design and implementation of clean energy solutions including solar, battery, fuel cell and hydrogen generation systems. Through its subsidiaries, it also provides environmental systems and security systems integration. OTCQB-listed, H/Cell Energy is headquartered in Dallas, Texas.

The Company serves the residential, commercial, as well as government sectors. It has developed and implemented a hydrogen energy system used to completely power a residence or commercial property with clean energy. This is so it can run independent of the utility grid and also provide energy to the utility grid for monetary credits. The innovative system uses renewable energy as its source for hydrogen production.

The design of the HC-1 system is to provide clean energy for a better environment. The system eliminates the electric bill and dependence on fossil fuels. In addition, it allows one to benefit with tax and energy credits while helping make the environment safe for future generations. The HC-1 system is completely scalable. Upon installation, the HC-1 system operates as a self-sustaining energy system providing electricity and/or hydrogen fuel for transportation.

The design of each HC-1 system is to accommodate the electrical loads for an end user. The system can be configured to meet any kilowatt hour (kWh) demands. The installation includes solar panels, a hydrogen generator, a fuel cell and a tank, which would be located exterior to the property with the battery system located interior to the property.

In December, H/Cell Energy announced that it was awarded $600k in new projects for environmental systems and general contracting. These projects include work to be completed at different locations in the United States and Australia. These include Chester County Hospital, Total Wine & More, Petco, Workspace, TD Ameritrade, Wavell Heights, Kelvin Grove Early Learning Center, Mooloolaba Esplanade, Department of Agriculture & Fisheries, Biloela State High School, and Yarrabah Schools.

H/Cell Energy Corporation (HCCC), closed Tuesday's trading session at $0.84, even for the day, on 2,785 volume. The average volume for the last 3 months is 2,168 and the stock's 52-week low/high is $0.25/$1.60000002.

chart

International Land Alliance, Inc. (ILAL)

TipRanks, Stockopedia, InvestorsHub, OTC Markets, Stock News, Stockwatch, GlobeNewswire, Simply Wall St, Nasdaq, Morningstar, Dividend Investor, last10k, and Investors Hangout reported previously on International Land Alliance, Inc. (ILAL), and today we report on the Company, here at the QualityStocks Daily Newsletter.

International Land Alliance, Inc. is a worldwide land investment and development company based in San Diego, California. Its focus is on acquiring attractive raw land chiefly in Northern Baja California, often within driving distance from Southern California. The Company’s main objective is to sell desirable properties, at competitive prices, with favorable financing options for individual purchases and/or bulk purchases appropriate for all types of investors and buyers. International Land Alliance lists on the OTC Markets Group’s OTCQB.

International Land Alliance offers the option of financing with a guaranteed acceptance on any purchase for every customer. Through removing the middleman, loans are approved directly by the Company. This provides easy and affordable financing terms. Furthermore, there are no prepayment penalties, credit or background checks, and very competitively low interest rates.

The Company’s inventory includes properties that are residential, commercial, recreational, waterfront, ranch, hotel, and marina. International Land Alliance, via its wholly owned subsidiary, International Land Alliance, S.A. de C.V, a Mexican corporation, is the owner of 123 residential lots and commercial lots comprising a total of 20-acres, named Valle Divino, located in Ensenada, Baja California.

In addition, the Company is the owner of 1,344 residential lots and commercial lots comprising 497-acres, called Oasis Park Resort, located in San Felipe, Baja California. The Oasis Park Resort and Valle Divino Resort projects will undergo development as a second home resort or retirement destination in a planned community setting. International Land Alliance’s Villas Del Enologo at Rancho Tecate is a 2.6 acre parcel within the prestigious Rancho Tecate. It is a planned 24 -2B/2B Vineyard Villas with private wine cellar.

International Land Alliance closed in 2019 on the purchase of 80 acres, the Emerald Grove Estates, and an 8,000 square foot event facility, the Chateau at Emerald Grove, in the wine country in Southern California for $1.1 million. It entered into a 3-year lease with future plans of development.

International Land Alliance also signed a Letter of Intent (LOI) in 2019 to acquire roughly one acre of land with the plans and permits for 36 condominiums within the Bajamar Ocean Front Golf Resort. The Bajamar Ocean Front Golf Resort is a master planned golf community. It is 45 minutes south of the San Diego-Tijuana Border along the scenic toll road to Ensenada. The new project is branded “Costa Bajamar Oasis”.

This past November, International Land Alliance announced it completed site preparation for Costa Bajamar Oasis, its new residential project at the Bajamar Ocean Front Golf Resort. This major development further allows the Company to start taking advantage of its earlier announced agreement with CleanSpark, Inc. (CLSK) to deploy innovatively designed microgrid solutions.

International Land Alliance also announced in November 2019 the appointment of Mr. Manuel Garcia as Director of Operations. Before joining the Company, Mr. Garcia was the Director of Sales at Rancho Tecate Resort. There, he oversaw land sales, operations, development of sales strategies, as well as new areas of business development.

International Land Alliance, Inc. (ILAL), closed Tuesday's trading session at $1.13, off by 4.2373%, on 5,710 volume with 14 trades. The average volume for the last 3 months is 19,458 and the stock's 52-week low/high is $0.270099997/$5.00.

chart

Marizyme, Inc. (MRZM)

Spotlight Growth, Wolf Street, Street Insider, Whale Wisdom, Barchart, Seeking Alpha, Stockhouse, GlobeNewswire, Simply Wall St, Corporate Information, Wallet Investor, Accesswire, InvestorsHub, Dividend Investor, Stockopedia, last10k, Stockwatch, TradingView, GuruFocus, Investing.com, and OTC Markets reported earlier on Marizyme, Inc. (MRZM), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

A biotechnology company, Marizyme, Inc. focuses on acquiring late-stage drug assets to develop for use in the acute care space. A development-stage enterprise, its dedication is to the commercialization of therapies that address the urgent need relating to higher mortality and costs in the acute care space. The Company was previously known as GBS Enterprises Incorporated. Marizyme’s shares trade on the OTC Markets Group’s OTCQB.

The Company brings late stage pharmaceutical products to market that are undervalued or need experienced leadership to monetize. Marizyme has clinically tested and patented use of protease therapeutic platform or Krillase® for the treatment of acute ischemic stroke, acute myocardial infarction, deep vein thrombosis and chronic wounds/burns. Krillase® is classified as a biological drug. Nonetheless, it has been classified as a Class III medical device in Europe for treating chronic wounds.

Krillase™ is a combination of endo and exopeptidases, which safely and efficiently breaks down thrombogenic material and necrotic tissue. Krillase® safely dissolves arterial thrombogenic plaque safely and efficiently. Fundamentally, Krillase® is a “biochemical knife”. It breaks down necrotic tissue and thrombogenic material that can mitigate or treat numerous disease states in humans. It will initially be delivered as a sterile, lyophilized powder with a long shelf life.

This past October, Marizyme announced that it agreed to exclusively distribute Somahlution's DuraGraft® products in Mexico and South America. Somahlution, LLC. is a privately held international biotechnology company. It develops unique products that address critical unmet medical needs in Ischemia Reperfusion Injury (IRI), using revolutionary technologies to advance human health.

This agreement also gives Marizyme the exclusive right to manufacture those products in Chile where it has relationships to create manufacturing and distribution channels and extend them into the rest of South America.

DuraGraft® is a one-time intraoperative vascular graft treatment used during vascular surgery to lessen the incidence of complications associated with graft failure and improving clinical outcomes by maintaining normal graft function. DuraGraft mitigates Ischemic Injury to maintain endothelial function and structure during the storage interval.

Marizyme, Inc. (MRZM), closed Tuesday's trading session at $1.71, up 10.3226%, on 1,846 volume with 8 trades. The average volume for the last 3 months is 990 and the stock's 52-week low/high is $0.310000002/$2.0999999.

chart

AgraFlora Organics International, Inc. (AGFAF)

Marijuana Stocks, TipRanks, Pot Stock News, TradingView, Investing.com, Stockhouse, The Street, Pot Stocks, IRW Newsletter, Investors Hub, The WS News Publisher, Nasdaq, Dividend Investor, GlobeNewswire, and Stockwatch reported previously on AgraFlora Organics International, Inc. (AGFAF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

AgraFlora Organics International, Inc. is a growth oriented and diversified international cannabis company listed on the OTC Markets. It owns an indoor cultivation operation (ACMPR licensed- 8,800 sq. ft.) in London, Ontario. In addition, the Company is a joint venture (JV) partner (a 70 percent interest) in Propagation Service Canada and its large-scale 2,200,000 sq. ft. greenhouse complex in Delta, British Columbia. AgraFlora Organics International has its corporate headquarters in Vancouver, British Columbia.

The Company has a world-class team with broad experience with natural farming techniques, biodynamics, genetics and strains. The foundation of AgraFlora’s products is on a very large library of proprietary genetics in clone and seed form that have been bred in first-rate conditions.

AgraFlora Organics is a vertically integrated cannabis enterprise equipped with a strong portfolio of licensed upstream, downstream and product formulation assets. Furthermore, it operates a flagship 51,500 sq. ft. edibles manufacturing facility in Winnipeg, Manitoba. The Company’s brands include Canutra Naturals Ltd., Edibles and Infusions, HowlBrands, Whole Hemp Health, Eurasia Infused, True Focus, Potluck, and Health Cap Holdings.

AgraFlora Organics International announced this past September that its wholly-owned subsidiary Canutra Naturals was awarded a cannabis research licence by Health Canada under the Cannabis Regulations Act. The Research License permits Canutra Natural to pursue the development of proprietary cannabis genetics and phenotypes at its flagship 76-acre campus in Kent County, New Brunswick.

Earlier this month, AgraFlora Organics International announced the introduction of four innovative cannabinoid infused Stock Keeping Units (SKUs) for production at its 51,500 square foot GMP Winnipeg Edibles Facility. The Company’s intention is to produce pectin and/or gelatine based CBD (cannabidiol) or THC (Tetrahydrocannabinol) infused gummy SKUs branded with Mesoamerican attributes.

It will produce the following: Rojo - a strawberry flavoured pectin based cannabinoid-infused gummy SKU; Naranja - a tangerine flavoured gelatine based cannabinoid-infused gummy SKU; Azul - a blue raspberry flavoured gelatine based cannabinoid-infused gummy SKU; and Verde - a green apple flavoured pectin based cannabinoid-infused gummy SKU.

Last week, AgraFlora Organics International announced it received a purchase order from Gateway Newstands for its Whole Hemp Health (WHH) organic lip balm SKU. Gateway’s purchase order and subsequent listing of a secondary AgraFlora SKU secures added high-visibility Canadian shelf space for AgraFlora’s growing line of organic cannabis sativa seed oil infused consumer packaged goods (CPGs). AgraFlora was awarded approved supplier status by Gateway on October 9, 2019. The Company now has two unique SKUs on the shelves of Gateway’s 200 high-traffic storefronts.

AgraFlora Organics International, Inc. (AGFAF), closed Tuesday's trading session at $0.079805, up 30.1218%, on 1,893,335 volume with 171 trades. The average volume for the last 3 months is 773,122 and the stock's 52-week low/high is $0.050999999/$0.639699995.

chart

Nutra Pharma Corp. (NPHC)

Serious Traders, PennyStocks24, StocksToBuyNow, Pumps and Dumps, Winston Small Cap, Streetwise Reports, MyBestStockAlerts, BUYINS.NET, UndiscoveredEquities, Wallstreetlivechat, and Innovative Marketing reported earlier on Nutra Pharma Corp. (NPHC), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Nutra Pharma Corp. is a biotechnology company listed on the OTC Markets. The Company specializes in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases. These include Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain. Nutra Pharma is marketing Nyloxin® and Pet Pain-Away™ in the Over-the-Counter (OTC) pain management market. Founded in 2000, Nutra Pharma is based in Coral Springs, Florida.

By way of its subsidiaries, the Company carries out basic drug discovery research and clinical development. The focus of its approach to drug discovery and the development of new therapeutic agents are based on specialized receptor-binding proteins found in nature, particularly those found in snake venom from the cobra.

Nutra Pharma’s leading drug candidates are RPI-78M and RPI-MN. Its MS drug RPI-78M was earlier granted Orphan Status by the Food and Drug Administration (FDA) for the treatment of Pediatric Multiple Sclerosis. Nutra Pharma’s RPI-MN inhibits the entry of many viruses known to cause severe neurological damage in diseases such as encephalitis and AIDS. RPI-MN is undergoing development initially for the treatment of HIV. RPI-78M is undergoing development for the treatment of multiple sclerosis (MS).

Additionally, Nutra Pharma looks for strategic licensing partnerships to reduce the risks associated with the drug development process. The Company’s holding, ReceptoPharm, is developing technologies to produce drugs for HIV and MS.

Nutra Pharma’s Designer Diagnostics subsidiary engages in the research and development (R&D) of diagnostic test kits designed to be used for the quick identification of infectious diseases. These include Tuberculosis (TB) and Mycobacterium avium-intracellulare (MAI).

Nutra Pharma offers several drug products for sale for pain treatment. One is Nyloxin®, the first OTC pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. The Company has launched Luxury Feet. This is a new version and packaging of its OTC pain drug Nyloxin. Another product is Nyloxin Extra Strength. This is the only non-narcotic and non-addictive treatment for severe (Stage 3) pain. Moreover, the Company has its Pet Pain-Away. This is the first OTC product to treat pain in companion animals without side effects. Pet Pain-Away is a homeopathic, non-narcotic, non-addictive, OTC pain reliever.

In September 2018, Nutra Pharma announced that its work with EuroAmerican IP, LLC resulted in a listing of its Nyloxin® product line on the website, www.GoVets.com. GoVets is the online marketplace under the National Veteran Small Business Coalition (NVSBC) to buy from VA-verified Service-Disabled Veteran-Owned Small Businesses (SDVOSBs).

With growing concern regarding consumers using opioid and acetaminophen-based pain relievers, Nyloxin® offers an alternative, which does not rely on opiates or non-steroidal anti-inflammatory drugs, known as NSAIDs, for their pain relieving effects. Nyloxin® has a well-defined safety profile.

Nutra Pharma Corp. (NPHC), closed Tuesday's trading session at $0.0006, up 50.00%, on 263,510 volume with 10 trades. The average volume for the last 3 months is 4,014,238 and the stock's 52-week low/high is $0.000199999/$0.000699999.

chart

Guided Therapeutics, Inc. (GTHP)

NYC Marketing Inc., DSR News, PHUB News, TheNextBigTrade, PennyStocks24, TopPennyStockMovers, SmallCapVoice, PennyTrader Publisher, Pennystocktweeters.com, Stock Beast, OTCStars.com, BestDamnPennyStocks, PennyStockLocks.com, ResearchOTC, Stock Commander, StockRockandRoll, AllPennyStocks, and Momentum Trades reported on Guided Therapeutics, Inc. (GTHP), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTC Bulletin Board, Guided Therapeutics, Inc. is the creator of a fast and painless testing platform. This platform is for the early detection of disease founded on the Company's patented biophotonic technology that uses light to detect disease at the cellular level. The Company’s initial product is the LuViva® Advanced Cervical Scan. This is a non-invasive device used to detect cervical disease rapidly and at the point of care. Guided Therapeutics has its corporate office in Norcross, Georgia.

The LuViva® Advanced Cervical Scan is an investigational device. It is limited by federal law to investigational use in the United States. The design of LuViva® is as a fast, painless test that, unlike Pap smears and HPV testing, does not necessitate a tissue sample or the delay of laboratory analysis.

LuViva® scans the cervix with light. It utilizes spectroscopy to measure how light interacts with the cervical tissue. Spectroscopy identifies chemical and structural indicators of pre-cancer, which may be below the surface of the cervix or misdiagnosed as benign.

This technique is called biophotonics. Biophotonics is the science of generating and harnessing light to image, detect, as well as manipulate biological materials.

The LuViva® Advanced Cervical Scan technology (in a multi-center clinical trial, with women at risk for cervical disease) was able to detect cervical cancer up to two years earlier than conventional modalities, according to published reports. The device is used in combination with the LuViva® Cervical Guide single-use patient interface and calibration disposable.

The LuViva® Advanced Cervical Scan is under U.S. Food and Drug Administration (FDA) Premarket review. Guided Therapeutics is also developing a non-invasive test for the early detection of esophageal cancer utilizing this technology platform.

At the beginning of this month, Guided Therapeutics reported record sales for a quarter in Indonesia; eight LuViva® Advanced Cervical Scans were shipped in Q4 of last year. Furthermore, Indonesia ordered 4,500 single-use Cervical Guides that were shipped along with the LuViva devices.

This increase in orders of high-margin Cervical Guides indicates that installed LuViva units are starting to see more usage in hospitals and clinics. Founded on prior studies and evaluations of LuViva, medical researchers in Indonesia are recommending the LuViva test as an alternative to the Pap test for cervical cancer screening.

In addition, this month, Guided Therapeutics reported that it received Regulatory Approval from the Indian Ministry of Health & Family Welfare to permit commercialization of the LuViva device and disposables. The Ministry concluded that the LuViva device is “Non Invasive” and therefore is “not regulated under the Drugs and Cosmetics Act 1940 and Medical Device Rules 2017 thereunder.” Consequently, LuViva can now be commercialized in India.

Guided Therapeutics, Inc. (GTHP), closed Tuesday's trading session at $0.179, up 34.9925%, on 85,528 volume with 18 trades. The average volume for the last 3 months is 11,492 and the stock's 52-week low/high is $0.0206/$1.45000004.

chart

Sauer Energy, Inc. (SENY)

Winston Small Cap, Shiznit Stocks, PennyStocks24, Fast Money Alerts, Penny Stock General, RockingPennyStocks, StockHideout, Investment U, DSR News, The Next Big Trade, Penny Stock Hub, BestDamnPennyStocks, and Stock Shock and Awe reported previously on Sauer Energy, Inc. (SENY), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Sauer Energy, Inc. is a technology developer and manufacturer. The Company is concentrating on the developing renewable energy market. It is the developer of the patented WindCharger™ brand vertical axis wind turbine (VAWT) and the manufacturer of the patented HelixWind® vertical axis wind turbine. Sauer Energy is uniting wind, solar, and storage together in harmony so that energy can be harnessed and processed to the greatest advantage. Sauer Energy’s head office and manufacturing facility is in Oxnard, California.

The Company is addressing worldwide energy through developing complete renewables packages by way of three energy sources that can help ensure the optimization of opportunities to capture the elements and produce electricity quicker, simultaneously, and individually. It created the WindCharger™ model to provide a better solution for the use of wind capture for residential or small building use. The WindCharger™ is one of its vital innovation priorities. Sauer Energy has several patents in place and more pending.

The design of Helix vertical axis wind turbine systems is purposely to be pole mounted and can respond to the demand for applications that do not necessitate roof mounting. Sauer’s technology requires few parts. Therefore, it provides a new direction for wind capture, scales easily from residential to small community and up to large industrial scale.

Sauer and Helix turbines underwent development to produce a quiet and low-impact technology with a high output of sustainable renewable energy. The focus of the WindCharger™ and Helix turbines has centered on patented disruptive technology, minimum impact on the environment, mounting flexibility, and versatility with highly efficient output.

The Company’s WindRider® turbine has a new mount and its own proprietary system for on-grid or off-grid structures. The Company’s intention is to offer the patented helixical WindRider® model vertical axis wind turbine that uses the HelixWind technology.

Sauer’s WindCutter turbine is a very powerful Darrieus design. The WindCutter has five airfoil blades that use the principle of lift to rotate the shaft. It is pole mounted. The Company’s WindCutter 2.5, VAWT design is the first model cleared for launch.

This past October, Sauer Energy had on view its WindCutter™ turbine solution at the Willow Springs International Motorsports Raceway, in Rosamond, California. With the installation completed and on display anyone could witness the WindCutter in operation as it produced power. The Company’s aim is to always improve technological advancements through finding new ways to make power more efficiently.

Mr. Dieter Sauer, Sauer Energy’s Chief Executive Officer and President said in late October, “What a milestone achievement for the SEI team as we enter a new chapter in our history.”

Sauer Energy, Inc. (SENY), closed Tuesday's trading session at $0.0046, up 46.0317%, on 74,034 volume with 12 trades. The average volume for the last 3 months is 98,500 and the stock's 52-week low/high is $0.0006/$0.017899999.

chart

Lithium Corp. (LTUM)

Breaking Bulls,  OTCPicks, SmarTrend Newsletters, PickPennyStocks,   FNNO Newsletters,  AllPennyStocks, Stockpalooza,   Canadian Microcap Report, and Stockdigest Report reported previously on Lithium Corp. (LTUM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter. 

Lithium Corp. engages in the identification, acquisition, and exploration of metals and minerals with  an emphasis on lithium mineralization on properties in Nevada.  The  Company’s   commitment  is to the exploration for energy storage related resources  across  North America,  looking  to capitalize on opportunities within the  growing  next generation  energy storage  markets.  An exploration stage mining company,  Lithium  is headquartered  in Elko, Nevada.

The Company maintains a strategic alliance with Altura Mining. Lithium’s flagship  property is  Fish Lake Valley.  At Fish Lake Valley,  it  holds Placer claims  that cover roughly 7,800 acres.  The Fish Lake Valley Property is in northern Esmeralda County in west-central Nevada.

In  north-western Nevada, Washoe County, Lithium has its San Emidio Project. The Company  staked a block of claims in the San Emidio Valley during September of  2011, and  presently  holds 1,600 acres.

Additionally, it has its North Big Smokey lithium brine exploration property in Big Smokey Valley, Nye County, Nevada.  This property is on federal lands. It consists of 44 association placer claims,  most which are 80 acres. In total the prospect is approximately 3,400 acres.

Lithium  has its BC Sugar Property situated in Shuswap, B.C. It  has assembled a 19,816-acre (8,019 hectare) block of mineral claims in  B.C.  that is highly prospective for hosting commercially extractable deposits of flake graphite.   

  Furthermore, the Company has its Hughes Property in  Tonopah, Nevada.  Lithco participated in the  establishment of Summa LLC,  a private Nevada Limited Liability company that  holds 88 fee-title patented lode claims that cover about 1,191.3 acres of prospective mineral lands.  Lithium signed a Joint Operating Agreement with the other participants to govern the conduct of Summa, and the development of the lands.

This past October,  Lithium announced that it recently excavated a ''mini bulk'' sample at its BC Sugar flake graphite prospect in B.C. This sample was submitted to SGS Lakefield's laboratory in Burnaby, B.C. 

Elsewhere in B.C, the Company has ended work on the Bormal option properties. It is now awaiting final assay results from these new Rare Earth Element/Tantalum-Niobium prospects. The results will include further assays from a zone discovered in July 2017 where initial assays indicated Total Rare Earth Element (TREE) content was up to 0.75 percent.

In December, Lithium announced that Summa LLC, which Lithium owns a 25 percent interest in, recently entered into an agreement where it will sell a 100 percent interest (subject to a ½ percent Net Smelter Royalty or NSR) in the 20-acre Copper Chief patented mineral claim in Nevada for $103,000. Moreover, Summa received an offer to option its other four patented claims in the Goodsprings Mining District.

Lithium’s President, Mr. Tom Lewis, is a Managing Member of Summa, which holds manifold properties across Nevada, which originated from Howard Hughes’s Summa Corporation.

Lithium Corp. (LTUM), closed Tuesday's trading session at $0.10, up 32.4503%, on 147,442 volume with 31 trades. The average volume for the last 3 months is 62,212 and the stock's 52-week low/high is $0.047499999/$0.150000005.

chart

American Power Group Corp. (APGI)

Marketbeat.com, Stock News Now, and SmallCapVoice reported on American Power Group Corp. (APGI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

American Power Group Corp. designs and produces proven alternative fuel solutions for stationary power generators, backup power systems, and commercial transportation. The Company’s alternative energy subsidiary, American Power Group, Inc. (APG), provides a cost-effective patented Turbocharged Natural Gas® Dual Fuel Conversion Technology for vehicular, stationary, as well as off-road mobile diesel engines. American Power Group is headquartered in Lynnfield, Massachusetts and lists on the OTC Markets Group’s OTCQB.

The Company’s patented Turbocharged Natural Gas® Dual Fuel Conversion Technology is a unique non-invasive software driven solution. It converts existing vehicular and stationary diesel engines to run simultaneously on diesel and different kinds of natural gas. This includes compressed natural gas, liquefied natural gas, conditioned well-head/ditch gas or bio-methane gas with the flexibility to return to 100 percent diesel fuel operation at any time. It is a ground-breaking non-invasive energy enhancement system.

American Power Group (with its proprietary Flare to Fuel™ process technology) can convert captured gases into natural gas liquids (NGLs) that can sell as heating fluids, emulsifiers, or be further processed by refiners. Via the Company’s Trident Associated Gas Capture and Recovery Technology, it can provide oil and gas producers a flare capture service solution for associated gases produced at their remote and stranded well sites.

Regarding American Power Group’s dual fuel, methane gas is metered into a diesel engine's air intake, before the turbocharger, by the air filter. As the enriched air/gas mixture increases the engine's power, the diesel's own governor senses the power increase and backs off on diesel flow. The system maintains a balance of gas-to-diesel ratios.

The maintaining of the energized fuel balance is with a proprietary read-only electronic controller system. This ensures the engines operate at original equipment manufacturers' (OEMs) specified temperatures and pressures. Installation on a broad collection of engine models and end-market applications demands no engine modifications.

Yesterday, American Power Group announced that it will extend the filing of its June 30, 2017 Quarterly Form 10Q through SEC Form 12b-25. The Company announced on June 6, 2017, a corporate wide realignment of its strategic direction, reallocation of resources, and reduction in workforce in response to considerable operating losses because of the effect that ongoing low oil prices were having on its dual fuel and flare capture businesses. The realignment resulted in a decrease in annual operating costs of greater than $2 million on a going forward basis.

American Power Group Corp. (APGI), closed Tuesday's trading session at $0.00951, up 50.00%, on 11,500 volume with 6 trades. The average volume for the last 3 months is 33,920 and the stock's 52-week low/high is $0.002899999/$0.100000001.

chart

eWellness Healthcare Corp. (EWLL)

Penny Stock Prodigy and StockHideout reported earlier on eWellness Healthcare Corp. (EWLL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Culver City, California-based eWellness Healthcare Corp. develops a telemedicine platform. This platform is for providing Distance Monitored Physical Therapy programs. These programs are for pre-diabetic, cardiac, and health challenged patients via contracted physician practices and healthcare systems. The Company has launched PHZIO. The design of this telemedicine platform is to extend and scale a physician’s practice. eWellness Healthcare is the first physical therapy telemedicine enterprise to provide insurance reimbursable real-time distance monitored treatments. eWellness Healthcare lists on the OTC Markets Group’s OTCQB.

The Company’s business model is to license its PHZIO platform to any physical therapy (PT) clinic in the United States and/or have large-scale employers use its PHZIO platform as a completely PT monitored corporate wellness program. eWellness Healthcare’s PHZIO is a Physical Therapy Telemedicine platform. It extends a traditional practice online.

The chief features of the PHZIO platform include video treatment protocols, real-time patient monitoring, patient induction forms, a patient video journal, and post treatment evaluations. In addition, main features include integrated billing, patient metrics, and user administration & customization.

Moreover, PHZIO scales a practice’s billable rates. It also provides tools to make growing a business easier. Pertaining to the Patient Dashboard, the PHZIO Dashboard enables clients to login securely to access prescribed treatment protocols. PHZIO is user-friendly and highly reliable to operate for PT and Patient. Furthermore, it’s a total on-line PT telemedicine intervention system.

eWellness Healthcare has launched a PHZIO PT clinic on-boarding website. The site includes a telehealth profitability calculator to illustrate to prospective PT clinics the additional profits they can make through using the PHZIO platform.

eWellness Healthcare anticipates adding Artificial Intelligence (AI) tools and predictive analytics into its PHZIO platform by the end of this year. The anticipation is that the new AI and predictive analytics will combine the Company’s existing remote monitoring capabilities with machine learning and intelligent analytics, which take advantage of patient health data to improve healthcare outcomes.

Evolution Physical Therapy has added eWellness Healthcare's Telehealth PT Services at its four clinical locations in Los Angeles, California. This includes Culver City, Playa Vista, Beverly Hills, and Brentwood. Mr. Darwin Fogt, Chief Executive Officer of eWellness Healthcare, owns Evolution Physical Therapy.

Last week, eWellness Healthcare and Total Release Physical Therapy announced an Integration & Marketing Agreement. Total Motion Release Seminars (TMR) is a proprietary physical therapy methodology developed by Mr. Tom Dalonzo-Baker, MPT. TMR is a full-body oriented assessment and treatment approach. TMR helps patients lessen their pain and impairments which limit their function. The treatment approach is created to allow physical therapists to interact and treat their patients remotely. The expectation is that integration with PHZIO will be extensively adopted within the TMR community.

eWellness Healthcare Corp. (EWLL), closed Tuesday's trading session at $0.0007, up 40.00%, on 7,649,957 volume with 150 trades. The average volume for the last 3 months is 5,175,365 and the stock's 52-week low/high is $0.000399999/$11.50.

chart

The QualityStocks Company Corner

No Borders Inc. (OTC: NBDR)

The QualityStocks Daily Newsletter would like to spotlight No Borders Inc. (NBDR).

No Borders (OTC: NBDR), a Nevada corporation, today announced that it successfully raised a limited amount of capital via its SEC qualified RegA offering with share sales to both institutional and private investors prior to 2019 calendar/company fiscal year end. According to the update, No Borders and its subsidiaries are committed to operating with a focus on brand and revenue growth from a lean operations ideology. To view the full press release, visit http://ccw.fm/A4hBl. Also today, the company was highlighted in a publication from CBDWire, examining how, nearly 40 years ago, a pre-digital era hacker generated alarm and panic by adding poison to store shelf Tylenol capsules and repackaging the medication so that the tampering wasn’t evident (http://cnw.fm/NBO9r). The deaths that resulted from the hack drove innovation that has since made tamper-resistant bottle technologies standard in consumer markets. Blockchain is becoming the 21st century iteration of tamper-proof technology, and tech solutions provider NBDR is one company in the industry that is working to establish confidence-building supplier-to-consumer protocols that make it far more difficult for malicious individuals to interfere with the production chain without detection, and for unintended taints by legitimate operators to remain untraceable.

No Borders Inc. (OTCQB: NBDR) specializes in the acquisition, creation and scaling of commercial products by utilizing cutting-edge technologies designed to reduce costs while increasing revenues and shareholder value. With active subsidiaries in healthcare, education, cannabidiol (CBD), finance and technology, No Borders is uniquely positioned to use its expertise to improve margins and add business lines within target verticals. No Borders is headquartered in Arizona with remote work resources in the U.S., South America, Asia and Europe.

Different by Design

Deeply experienced at actionable data compilation, analysis and utilization, No Borders believes that data utilization in a Web 3 ecosystem of predictive analytics, blockchains, consensus algorithms, IoT and 5G are vital keys to the future of disrupting global business.

The company leverages its technological talent and visionary approach alongside best-in-class branding, messaging and product teams to simultaneously deploy multiple vertical product offerings at the same time.

With resources around the world, No Borders operates as a 100% remote work, lean operating organization with a founding ideological focus on “Lifestyle by Design.” No Borders’ teams are built by allowing people to work when they want and from where they want as long as deliverables and results are achieved. This structure allows for strategic talent acquisition without the need for relocation or commuting; lowered operating and fixed costs; as well as improved morale and substantially increased staff productivity.

NBDR Companies

  • No Borders Dental Resources Inc. provides equipment and supplies to medical and dental professionals across the U.S. through the trade name, MediDent Supplies. MediDent has a strategic focus on expanding product portfolios and optimizing lifetime customer value while minimizing customer acquisition cost in the medical, dental and veterinary spaces.
  • No Borders Naturals is a purveyor of health and wellness products for active consumers and their pets. No Borders Naturals aims to be an industry leader in alternative wellness product offerings and is currently expanding its digital offering with impactful product up-sell opportunities such as a series of “Buy Two-Get One” on products on its 1000mg CBD tincture, collagen and retinol beauty cream.
  • No Borders Labs Inc. provides leading-edge tech tools to the No Borders family of companies along with building, testing and deploying technology solutions and products to the market while also offering consulting, architecture and software development services to external businesses looking to update their technology infrastructure for greater efficiency, security and transparency.
  • No Borders Funding Inc. provides internal capital and strategic funding options for the family of No Borders companies while actively engaging and networking to find, acquire, structure and deploy unique financial products, solutions and systems with traditional, distributed ledger and blockchain technologies.
  • No Borders Education Inc. provides internal staff training and strategic education tools for the No Borders family of companies while pursuing external revenue generating educational opportunities within the verticals for which No Borders deploys products, services or technologies.

 

Leadership

No Borders CEO Joseph Snyder is a serial entrepreneur whose experiences in real estate investment, financial services and digital strategy over the last 15 years provide a strong, grounded foundation for the structure and ideas outlined in the company’s strategic plan. He brings a unique set of long-term business experiences that provide No Borders with a clear “mile-high” view of the intricately linked systems and challenges associated with growing and scaling our vision.

COO Cynthia Tanabe, a licensed real estate agent/broker since 2004, has successfully built a highly respected investor and bank-focused real estate and property management firm in Arizona with tens of millions of dollars of properties owned and sold.

CTO Chris Brown has 14 years of experience in the IT industry ranging from full stack programming, hardware support, engineering and maintenance, to enterprise-level information system analysis, design, development and implementation. From his background in Air Force intelligence to earning dual B.S. degrees in computational mathematics and biochemistry from Arizona State University, Brown has been engrossed with technologies such as artificial intelligence, machine learning, and decentralized blockchain ledger systems and their connections with real world business applications.

Management is backed by an advisory board with a diverse range of expertise blockchain, brand development, specialty retail, branded consumer products, technology, marketing and other specialties pertinent to No Borders’ growth strategy.

No Borders Inc. (NBDR), closed Tuesday's trading session at $0.0123, off by 3.1496%, on 235,650 volume with 24 trades. The average volume for the last 3 months is 95,890 and the stock's 52-week low/high is $0.007699999/$0.048799999.

Recent News

chart

Sigma Labs Inc. (NASDAQ: SGLB)

The QualityStocks Daily Newsletter would like to spotlight Sigma Labs Inc. (SGLB).

Sigma Labs Inc. (NASDAQ: SGLB) is set to exploit the tremendous aerospace 3D-printing-market growth potential with its revolutionary in-process, quality-assurance technology. This technology is poised to help the industry scale a critical hurdle: ensuring effective and efficient quality in real time. The global aerospace 3D-printing market was estimated at $1.4 billion in 2018, projected to reach $6.8 billion by 2026 with an expected CAGR in excess of 22% during the forecast period.

Software companies can prove to be exceptionally lucrative and rewarding when they provide critical solutions to complex problems. Sigma Labs Inc. (NASDAQ: SGLB) is in just such an enviable position. The company is the recognized pioneer in the development and commercialization of real-time, computer-aided inspection solutions for the 3D metal printing industry.

Sigma Labs Inc. (SGLB) is the only provider of in-process quality-assurance software to the commercial 3D printing metal industry that enables operators of machines making 3D metal parts to offset emerging quality problems, sustain part quality, and avoid rejects. Sigma’s software is the singular solution that enables both real-time, in-process detection of quality control manufacturing irregularities for critical metal parts and then provides the operator the actionable information needed to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality control process for the manufacture of 3D printed metal components. The nascent 3D metal printing industry is on the verge of radically altering the speed and technical complexity of manufactured parts. Further, it makes possible just-in-time availability of critical components – all at reduced cost, time, waste and weight. 3D printing, heralded as the fourth industrial revolution in manufacturing, will only truly surpass traditional techniques when the additive manufacturing industry moves from “post process” quality control to “in process” quality assurance.

For the industry to move from prototype manufacturing of critical components to economically viable commercial production, the 3D metal printing industry must find ways to dramatically increase production speed and quality yields, and to dramatically decrease the excessive cost of quality control. To achieve these prerequisites and move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality control problems must be identified in real-time and alerts must be issued. The problem, along with the solution, must then be communicated to the machine operator to implement repairs.

Revolutionizing Additive Manufacturing

Sigma Labs, with its PrintRite3D® brand, has established a new benchmark in the development and commercialization of real-time computer aided inspection (“CAI”) solutions. Sigma Labs resolves the major roadblocks and costly quality control challenges that impede the 3D manufacture of precision metal parts. The company’s breakthrough computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance during production, uniquely allowing errors to be corrected in real-time.

Sigma Labs was founded in 2010 by a team of Los Alamos National Labs scientists and engineers to develop and commercially license advanced metallurgical products for the military ordinance, dental implants, and then for additive manufacturing (3D printing). After assessing 3D metal printing technology and the costly, inconsistent quality control issues, Sigma Labs concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities in such a manner that reliability and repeatability of very high precision quality metal parts could be achieved in the process. Sigma Labs’ patented and third-party validated software has achieved these objectives and now delivers the critical elements needed to unleash the promise of 3D metal printing.

Sigma Labs’ products and services are engineered, manufactured and qualified for use in the highly demanding and hyper precise production environments of the aerospace, defense, transportation, oil and gas, biomedical and other precision-dependent industries.

The Challenge

Additive metal manufacturing combines multiple processes and parts into one single 3D printed part. Due to variances in the additive manufacturing process, parts of consistent quality currently can’t be reliably produced in either large or small quantities without substantial postproduction inspection and rejection costs. Parts are inspected after production using CT scans and other means, so the manufacturer doesn’t know until the very end which of the finished parts meet design specifications. This means lost time, lost profits and inability to economically scale up production.

Innovative Approach

Sigma Labs solves this problem with its patented, in-process quality control technology that informs operators and engineers how to improve both the manufacturing process and quality by capturing meaningful data about inconsistencies in real-time. Sigma Labs is also partnering with OEMs, working toward the visionary introduction of revolutionary closed-loop control that will bypass the machine operator and automatically make in process corrections by reducing machine variations.

Sigma Labs’ next generation technology gives manufacturers the ability to make fast, virtual real-time adjustments so that each finished part is uniform and within critical specifications, thereby improving production quality, decreasing end-users’ risks and waste, and increasing profits and speed to market. Sigma Labs’ PrintRite3D® IPQA Software monitors and assesses the quality of each production part in the 3D additive manufacturing process – layer by layer, and in real-time. This has never been available until now.

Sigma Labs maintains a strong intellectual property portfolio consisting of trade secrets, process know-how and 34 patents either granted, pending or awaiting pre-publication around the globe. These patents encompass the fundamental technologies underlying Sigma Labs’ melt pool process control, data analytics, anomaly detection, signature identification, and future “closed-loop control” of 3D metal printing.

Market Opportunity

Providing advanced quality assurance software to the commercial 3D printing industry is currently a $1.4 billion addressable market expected to grow to $3.9 billion by 2023. Integrating Sigma Labs’ groundbreaking software helps arm the industry with a necessary catalyst to help enable and optimize the fourth industrial revolution in manufacturing.

Sigma Labs’ global client base includes 23 installations across 19 different users. Tier-1 OEM enterprises and end-users such as Siemens, Honeywell, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.

Management Team

John Rice, CEO and chairman of the board of directors, has extensive experience as a CEO, lead negotiator, turnaround expert, business financier and crisis management executive/consultant. Prior to becoming chair and CEO of Sigma Labs, he was the CEO of a successful turn-around of a Coca-Cola Bottling Company. Rice has led a variety of companies in diverse business sectors and worked on a host of products and technologies including design and manufacture of high-end jet engine test equipment for the U.S. Airforce, chaff dispensers for F16s, software for modeling naval exercises, software for controlling warehouse distribution systems, medical radioisotopes, cancer detection, and cybersecurity. He is an honor’s graduate of Harvard College.

Darren Beckett, CTO, has over 20 years of experience in the semiconductor industry, including Intel Corporation, where he held various technical and managerial positions. His expertise in process engineering for advanced manufacturing technology includes statistical process control for fabrication of semiconductor devices.

CFO Frank D. Orzechowski also serves as treasurer, principal accounting officer, principal financial officer and corporate secretary. He has more than 30 years of distinguished financial and operational experience. Orzechowski began his career at Coopers & Lybrand in 1982, received his CPA certification in 1984, and received his Bachelor of Science in Business Administration with a major in accounting from Georgetown University in 1982.

Ronald Fisher, vice president of business development, is leading the commercialization of PrintRite3D® 5.0. Fisher is a mechanical engineer with hands-on experience in quality, manufacturing and product development. He has distinguished himself as a lead sales and marketing officer as well as a chief operating officer most recently before joining Sigma in technology startup that grew from market entry to successful exit by merger-acquisition.

Sigma Labs Inc. (SGLB), closed Tuesday's trading session at $0.98, up 1.2577%, on 54,115 volume with 93 trades. The average volume for the last 3 months is 196,687 and the stock's 52-week low/high is $0.451099991/$2.46000003.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com Inc. (OTCQB: CIIX) is a leading financial-information website for Chinese-speaking investors in the United States and China. CIIX CEO Warren Wang recently discussed the company’s goals and bright outlook for 2020 during a MoneyTV.net interview with Donald Baillargeon (http://cnw.fm/1bWeD).

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed Tuesday's trading session at $0.1739, up 11.4744%, on 52,571 volume with 28 trades. The average volume for the last 3 months is 52,971 and the stock's 52-week low/high is $0.150000005/$0.550000011.

Recent News

chart

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF)

The QualityStocks Daily Newsletter would like to spotlight HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF).

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) was featured today in a publication from HempWireNews, examining how in the United States, this year’s national elections promise to keep federal cannabis policy in the spotlight as the large majority of Democratic challengers are fine tuning their pro-pot policies and surveys are showing the majority of Americans prefer more sweeping legalization than federal agencies have been willing to pursue under presidential administrations thus far (http://cnw.fm/TPbv3).

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp biomass and cannabidiol (“CBD”) industry, as well as gas and liquid extraction. HTC’s extraction & purification systems are engineered to large-scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced.

Advanced Extraction Technologies

For more than 14 years, HTC has developed and optimized proprietary technology and purification systems used for biomass, gas and liquid extraction. These technologies include:

  • LCDesign® – Low-cost design for modular gas, liquid and biomass extraction systems optimizes plant design, thus reducing capital and operating costs.
  • PDOEngine™ – Software-based design algorithms accurately model and simulate gas, liquid and biomass extraction processing.
  • Delta Solvents™ – Custom-designed, ethanol-based solvent mixtures and additives that optimize production and reduce costs. Technology development is being conducted at HTC’s sponsored research facilities at the University of Calgary.

Delta Purification® Technology

HTC’s patented Delta Purification® technology will purify, recycle and reuse the extraction ethanol used in the CBD extraction process while managing and reducing any CBD waste losses through the re-extraction of all wastes collected from the purified ethanol. Current and new technologies include:

  • Delta CBD Reclaiming System: Reclaiming and purifying ethanol for use in CBD extraction from biomass. Reduces required heat to prevent damage of the chemical attributes of the CBD molecule, allowing extracted CBD to meet food-grade targets for human consumption.
  • Delta Solvent Reclaiming System: Reclaiming and purifying ethanol-based solvents, such as single, mixed and formulated amines, for use in natural gas processing and post-combustion CO2 capturing processes.
  • Delta Glycol Reclaiming System: Reclaiming and purifying glycols, such as mono-ethylene glycol and tri-ethylene glycol for use in natural gas dehydration processes.

Hemp Biomass and Tolling Contracts

HTC has entered into a hemp biomass tolling agreement for the 2019 crop year involving a supply of hemp biomass from a hemp grower in Saskatchewan, Canada. The hemp grower utilizes five varieties of Health Canada-approved cultivars as the genetic foundation. HTC will process and extract CBD FSO distillate from the hemp biomass. As a tolling fee payment, HTC will receive a percentage of the extracted CBD FSO distillate for its processing, extraction, purification and distillation services.

Additional hemp biomass tolling contracts with producers and hemp biomass providers are being negotiated in the U.S. for the 2020 hemp crop growing year. HTC will provide “local-to-grower” drying-to-biomass storage capability and transportation of dried biomass to an HTC, location to be determined, future US based, extraction facility. HTC is also in negotiation with a 60,000-acre, recognized Canadian farm leader, who is a significant hemp biomass producer, for a similar hemp biomass tolling contract.

re3™ Technology

Large users of ethanol and solvents for plant oil extraction demand reduced capital and operating costs. HTC’s re3™ (reclaim, recycle, reuse) technology can save up to 30% of the required fluid costs. The increasing cost of new extraction ethanol, combined with the cost of used ethanol disposal, creates a unique opportunity whereby the re3™ technology will create cost savings, while meeting environmental responsibilities.

The growth of ethanol and CO2 used in CBD production has created a new demand for reliable commercial scale ethanol reclaimer systems. The Delta Purification® ethanol system meets this new demand.

Sales and Offtake Agreements

HTC intends to leverage its relationship with its related entity, Purely Canada Foods™, to provide sales and distribution for its Ingredient CBD market under the brand of Purely Canada Hemp™, Purely Canada CBD™, Purely Canada Cannabinoids™. Purely Canada Hemp™ will develop risk managed multi-year ingredient supply contracts with its existing and new Global Food, Beverage and Animal Food Industry Customers.

Project Construction

HTC has focused the Canadian implementation of its BOOM (build, own, operate and maintain) extraction tolling strategy on a location near Regina, Saskatchewan. HTC is currently constructing a 19,000-square-foot GMP Euro compliant extraction tolling facility on six acres of land that will include biomass processing, extraction, implementation of DeltaSolv™ technologies and Delta Purification® systems, distillate and refining equipment, laboratory quality control and testing operations, and on-site office and admin facilities.

Leadership

Chairman, CEO and Director Lionel Kambeitz is a recognized professional in business development and international business relations. He has played a founding role in many other Canadian and U.S.-based companies. Kambeitz has executive experience in a variety of industries including energy, agriculture, food production engineering, and manufacturing.

Jeff Allison, Senior Vice President, Chief Financial Officer and Director, has over 20 years of experience in corporate finance and business development. Prior to joining HTC in 2005, Allison as Vice President assisted with the founding and setup of CUCORP Financial Services in Saskatchewan.

HTC Extraction Systems (OTCQB: HTPRF), closed Tuesday's trading session at $0.152, even for the day, on 1,976 volume. The average volume for the last 3 months is 3,039 and the stock's 52-week low/high is $0.100299999/$0.920000016.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, this morning announced that it has reached a definitive agreement to provide its patented DehydraTECH(TM) technology to Cannadips CBD, the Original Smokeless CBD Dip Brand. According to the update, each tin of Cannadips contains 15 pouches, each with 10mg of hemp-derived CBD, and includes only natural sweeteners with no tobacco or nicotine. To view the full press release, visit http://cnw.fm/JFU8k. Also today, the company was highlighted in a publication from HempWireNews, examining how South Dakota’s governor, Kristi Noem, is considering giving the go-ahead to the development of a hemp industry law as long as it meets her requirements. On Thursday, Noem announced that although she is not in favor of hemp, she would not oppose the bill if the legislature approves it and it meets her requirements.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hemp-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.

Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.

In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.

Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.

Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Tuesday's trading session at $0.42, up 1.1008%, on 177,538 volume with 72 trades. The average volume for the last 3 months is 112,580 and the stock's 52-week low/high is $0.3037/$1.6875.

Recent News

chart

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)

The QualityStocks Daily Newsletter would like to spotlight Pacific Rim Cobalt Corp. (OTCQB: PCRCF).

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (FRANKFURT: NXFE), an Indonesia-based company focused on developing nickel-cobalt opportunities in the Asia-Pacific region, is pleased to report that Indonesia has approved environmental impact studies for factories to produce battery-grade nickel chemicals in Morowali, Coordinating Minister of Maritime and Investment Affairs Luhut Pandjaitan said on Wednesday*.

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) is a Canada-based exploration company focused on the acquisition and development of production-grade cobalt deposits, a key raw material input for the growing lithium-ion battery industry.

Pacific Rim Cobalt and its Cyclops Nickel-Cobalt Project, located in the Depapre District, Jayapura Regency, Papua Province, Republic of Indonesia, is uniquely positioned in a region with potentially the largest source of cobalt outside of Africa. Strategically located near China, the world’s largest cobalt buyer, the Cyclops Project is a laterite (iron-hosted) mineral prospect, rich in cobalt and nickel. Cobalt consumption in China is on-track to use over 8,000 tonnes of cobalt annually by 2021 for electric vehicle production alone and is projected to remain the world’s largest cobalt consumer for many years to come.

Global demand for renewable power is fueling a massive shift from traditional energy supply chain economics to cobalt-reliant lithium-ion batteries, the world’s most widely used power source for portable applications such as electric vehicles and other high-tech applications.

Pacific Rim Cobalt management has concluded that strategic access to major markets offers the most important factor to servicing the rising demand for cobalt. The company’s acquisition of its initial asset in Indonesia offers near surface, strong nickel-cobalt mineralization in an area with excellent infrastructure including a nearby workforce, supplies, sealed roads, ocean access, nearby port facility and gentle topography. The project area, nestled on the north coast of Papua, Indonesia, establishes Pacific Rim Cobalt well within the economically attractive ocean-going transportation range to Asia and its lucrative, growing industrial markets.

Exploration efforts are currently focused on establishing a maiden compliant resource for the Cyclops project, both in historically identified and drill-tested prospects as well as previously unexplored areas of the claims. During the first nine months of 2018, the company focused on assembling the necessary agreements to access northern areas of the project hosting historically identified mineralized zones. Mapping, sampling and a mini-bulk sample within the mineralized zones has been completed, along with a small-scale program in the previously unexplored far southern area of the project. With surface access to priority targets now established, Pacific Rim Cobalt will initiate drilling and extract additional mini-bulk samples for further metallurgical testing.

“We are excited and optimistic about the unique possibility of developing this project into an asset that will add shareholder value and position the company to play a future role in the battery metals supply chain,” Pacific Rim Cobalt CEO Ranjeet Sundher recently stated (http://nnw.fm/u1HNs). “We expect the near-surface nature of cobalt/nickel mineralization at the Cyclops project will lend itself well to low-cost, logistically straightforward drilling. We thus anticipate the opportunity to undertake a resource calculation study, as well as ongoing metallurgy and process option testing, will present itself in the near future. It’s going to be a busy year ahead, and we look forward to getting the drills turning and building value.”

Pacific Rim Cobalt’s world-class management team includes Sundher, who has over 20 years of capital markets experience. Sundher is also president of Canrim Ventures Ltd., a Singaporean advisory firm specializing in early stage project finance and structure. He previously founded Indogold Exploration, a Jakarta-based mining service firm, and has raised over $40 million for companies in which he was a founder/partner.

Chief Financial Officer Steve Vanry has 25 years of professional experience in senior management positions with public and private natural resources companies, providing expertise in capital markets corporate finance, mergers and acquisitions, regulatory compliance, accounting and financial reporting.

Andre Talaska serves as country manager and technical supervisor. He has over 30 years of experience in the mining and exploration industry and has held senior positions with several companies in Australia and southeast Asia. Shakir Juffry, business development/engineering, is a chemical engineer and extractive metallurgist by background training who has over 20 years of experience in the Indonesian mining and minerals exploration field. Toto Suarto Sajali, operation and development manager, is a mining engineer with over 15 years of experience in Indonesian project assessment, development and operations.

Pacific Rim Cobalt Corp. (OTCQB: PCRCF), closed Tuesday's trading session at $0.142, up 19.5789%, on 100,334 volume with 24 trades. The average volume for the last 3 months is 16,122 and the stock's 52-week low/high is $0.079999998/$0.259299993.

Recent News

chart

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Sharing Services Global Corporation (OTCQB: SHRG) is a diversified holding company that focuses on direct selling. SHRG owns or operates a variety of companies that sell products directly to consumers or provide services ranging from health and wellness, energy, technology and more. The company supports home-based entrepreneurs with direct-selling programs.

Sharing Services Global Corporation (SHRG), formerly Sharing Services Inc., is a diversified company dedicated to maximizing shareholder value, operating through two primary subsidiaries: Elepreneurs Holdings, a direct-selling company, and Elevacity Holdings, a products company. Headquartered in Plano, Texas, SHRG markets and distributes Elevate-branded health and wellness products through an independent sales force of distributors called Elepreneurs.

Proprietary Products

SHRG’s current exclusive Elevate product offerings are marketed under the Elevacity brand, so named to signify the company’s commitment to elevating lives.

The Elevate health and wellness product line consists of nutraceutical products that SHRG refers to as D.O.S.E., which stands for dopamine, oxytocin, serotonin and endorphins – all of which are key hormones proven to promote happiness and well-being.

Elevacity brand products are carefully formulated, chosen and designed to support a single objective: elevate the happiness and well-being of the consumer.

Global Network of Elepreneurs

Elevacity products are shared and sold by a growing international network of home-based entrepreneurs, called Elepreneurs, operated by Elepreneurs Holdings. This SHRG subsidiary provides basic and advanced programs for both new and experienced entrepreneurs who are focusing on their direct-sales careers.

SHRG’s high-performing independent sales force follows the company’s Blue Ocean selling strategy, an approach that encourages individuals to seek new markets, lead, and to “stop competing and start creating.” The Blue Ocean strategy is based on the book, “Blue Ocean Strategy,” written by Professor Renée Mauborgne, who notes that “the lesson here is that the best defense is offense, and the best offense… is to make a blue ocean shift and create your own blue ocean.”

Following this selling strategy, SHRG’s Elepreneurs are taught that, rather than competing directly in a competitive, direct-selling market, they should focus on making competitors irrelevant and succeeding in an uncontested marketplace.

In addition, SHRG’s Elepreneurs use the interactive, video-based VERB sales-marketing platform developed by Verb Technology Company Inc. The app utilizes proprietary interactive video data collection and analysis technology and provides next-generation customer relationship management, lead generation, and video marketing software applications.

Continued Momentum as Industry Leader

These selling strategies have resulted in sharp and consistent revenue gains. In the company’s 10-Q filed with the SEC for the three months ended Oct. 31, 2019, SHRG reported sales of $38.8 million for fiscal Q2 2019, an increase of 116% over sales of $17.9 million reported for the comparable quarter of 2018. Consolidated gross profit jumped by $16.2 million to $27.4 million for the same period compared to Q2 2018.

SHRG’s consolidated operating earnings were $3.9 million in the fiscal quarter ended Oct. 31, 2019, compared to $866,802 for the comparable period the prior year. Consolidated gross margin also grew 70.9% for the three months ended Oct. 31, 2019, compared to 62.2% the prior year.

These numbers are continuing a trend established over the past two years. In fiscal Q1 2019, SHRG achieved revenues of $35.4 million, more than double that of the comparable period in 2018. Even earlier, the company reported sales of $85.9 million for fiscal year ended April 30, 2019. This represents a nine-fold increase, or $77.5 million jump, over the company’s revenues of $8.4 million the prior year.

These numbers bring SHRG’s sales revenues since December 2017 — when the company’s Elevate product line was released — to an impressive cumulative total of $169 million.

Preparing for Success

SHRG is well prepared to continue and accommodate for this growth. The company recently expanded its corporate footprint by moving to a 10,000-square-foot facility in Plano, Texas, that offers ample room to expand as the company grows and flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

In addition, the company has a seasoned, expert leadership team in place, led by John “JT” Thatch. Thatch was appointed president and CEO of SHRG in March 2018, bringing to the company his expertise obtained from successfully starting, owning and operating several businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist SHRG as the company aims to expand and increase revenues.

Contact
469.304.9400 x 201
Info@SHRGinc.com
http://www.SHRGinc.com

Sharing Services Global Corporation (SHRG), closed Tuesday's trading session at $0.085, even for the day, on 10,125 volume with 3 trades. The average volume for the last 3 months is 28,344 and the stock's 52-week low/high is $0.065800003/$0.3944.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint, Inc. (SING) was featured today in a publication from HempWireNews, examining how South Dakota’s governor, Kristi Noem, is considering giving the go-ahead to the development of a hemp industry law as long as it meets her requirements. On Thursday, Noem announced that although she is not in favor of hemp, she would not oppose the bill if the legislature approves it and it meets her requirements. Also today, the company was highlighted in a publication from Investorideas.com, consisting of a sector snapshot looking at how cleantech may be the sector to watch in 2020. According to a report and outlook for 2020 by Deloitte, "For the first time ever, in April 2019, renewable energy outpaced coal by providing 23 percent of US power generation, compared to coal's 20 percent share. In the first half of 2019, wind and solar together accounted for approximately 50 percent of total US renewable electricity generation, displacing hydroelectric power's dominance."

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Tuesday's trading session at $0.0082, off by 6.8182%, on 3,560,648 volume with 90 trades. The average volume for the last 3 months is 3,287,649 and the stock's 52-week low/high is $0.007/$0.023499999.

Recent News

chart

Spectrum Global Solutions, Inc. (SGSI)

The QualityStocks Daily Newsletter would like to spotlight Spectrum Global Solutions, Inc. (SGSI).

Spectrum Global Solutions (OTCQB: SGSI), a leading single source energy management technology and network services provider, today announced its recent receipt of more than $4.8 million in new contract awards across all operating subsidiaries. To view the full press release, visit http://nnw.fm/SSae9

Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:

  • AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
  • ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
  • Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.

Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.

Market Opportunity

Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.

Management

CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.

Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.

Spectrum Global Solutions, Inc. (SGSI), closed Tuesday's trading session at $0.0365, up 3.5461%, on 80,262 volume with 13 trades. The average volume for the last 3 months is 83,521 and the stock's 52-week low/high is $0.014999999/$0.349999994.

Recent News

chart

Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF)

The QualityStocks Daily Newsletter would like to spotlight Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF).

Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) was featured today in a publication from CBDWire, examining how the cannabidiol (CBD) industry is a lot stranger than most sectors. For starters, most industries take a while to pick up steam and get rolling, but barely a year after CBD became legal, the market for the hemp extract is worth at least a billion dollars, and experts believe it will hit $20 billion by 2024. This is despite the fact that the industry is barely regulated, with the exception of the 2018 Farm Bill which legalized industrial hemp.

Willow Biosciences (TSX: WLLW) (OTCQB: CANSF), an emerging biotechnology company focused on the biosynthetic production of cannabinoids, is well positioned to disrupt the cannabis industry supply chain by utilizing its ability to provide biosynthetically derived cannabinoids. To view the full article, visit http://cnw.fm/DbQt5.

Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) is a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates. The company’s cannabidiol (“CBD”) yeast-based biosynthesis program produces a high yield, ultrapure, low-cost and scalable manufacturing solution for pharmaceutical, food, beverage and personal care consumers of CBD.

The company is headquartered in Calgary, Alberta, Canada.

Biosynthesis Platform

Willow’s proprietary yeast-based lab strains produce CBD, tetrahydrocannabinol (“THC”), and cannabigerol (“CBG”), as well as certain minor and novel cannabinoids.

The company’s expertise in the esoteric field of biosynthesis and in delivering commercial fermentation pathways for the production of pharmaceutical-grade compounds grew from its origins in opiate research. Willow recently delivered a de novo biosynthesis pathway in yeast for thebaine, a key precursor API used as a feedstock in the manufacture of semi-synthetic opiates such as naloxone (used to reverse opioid overdose) and several common analgesics. Led by Chief Scientific Officer Dr. Peter Facchini, Willow’s research team discovered and patented numerous previously unknown genes coding for core catalytic pathway enzymes, as well as a number of additional non-pathway, yet commercially-essential, accessory genes.

Utilizing this proven synthetic biology platform, Willow’s research team has already begun producing cannabinoids at lab scale, using yeast as the host cell “factory.” This biosynthetic fermentation-based process is capable of producing pharmaceutical grade CBD in 10 days – far less time than traditional plant-based extraction methods.

Willow anticipates its technology can be scaled to produce hundreds of kilograms per batch of cannabinoid API at less than $1,000 per kilogram, thus costing approximately 60% less than current chemical synthesis methods and 90% less than conventional plant-based extraction methods.

World-Class Collaboration

Willow and Noramco Inc., the world’s largest producer of high-quality synthetic cannabinoid APIs and other controlled substance APIs for the pharmaceutical and healthcare industry, have an exclusive, worldwide Joint Development Agreement (“JDA”) to design a yeast-based biosynthesis platform for the production and distribution of a highly pure CBD isolate.

The mutually exclusive agreement calls for Willow to be responsible for optimizing yeast strains in a biosynthetic process to generate ultrapure CBD at high yield and substantially lower cost compared to current methods. Noramco will leverage its decades of experience in producing and delivering CBD and pharmaceutical APIs by being responsible for the scale-up, regulatory submission, marketing and distribution of products manufactured under the JDA.

Each company will invest comparable funds, will retain the intellectual property associated with their respective scopes of work and share equally in gross profits from sales of products manufactured under the JDA.

Market Opportunity

The agreement with Noramco (http://nnw.fm/Mz1vW) addresses the increasing demand for CBD-based APIs and other CBD-infused products by pharmaceutical, nutraceutical, consumer packaged goods, beverages and other industry sectors.

The U.S. market potential of cannabinoids is significant, with industry analysts projecting $50 billion in cannabinoid-based pharmaceutical sales and $16 billion in CBD consumer goods retail sales by 2025. As of June 2019, 34 U.S. states and the District of Columbia, Guam, Puerto Rico and U.S. Virgin Islands have legalized cannabis for medical use. Another 13 states and territories have approved recreational cannabis for adult use while other states are considering similar measures.

The cannabinoid API market continues to evolve with CBD and other cannabinoid-based treatment options currently in clinical trials for indications such as post-traumatic stress syndrome, epilepsy, Parkinson’s disease, chronic pain, schizophrenia, cancer treatments and other challenging unmet medical conditions.

Capitalization

Willow is fully funded after raising $29 million via private placement and $8 million in exercised warrants by Tuatara Capital Fund II, L.P. Proceeds of the funding will be used to enhance the existing laboratory space in Calgary and Vancouver, Canada, and in San Francisco, California. The company anticipates exiting 2020 with $15.8 million in cash.

Leadership

President and CEO Trevor Peters is an experienced executive who co-founded four startup companies in the past 15 years. He has raised over $1 billion in equity and debt financings at various stages of corporate development and has been integral to successful transactions totaling over $4 billion on sale. Mr. Peters previously was chief financial officer at Caracal Energy Inc., which sold to Glencore plc in 2014 for $1.8 billion.

Chief Financial Officer Travis Doupe has over 18 years of experience in financial leadership roles, principally in the international oil and gas industry, where he provided corporate strategic direction while overseeing all aspects of financial operations. Mr. Doupe is the treasurer and a member of the board of directors of the Canada Council for the Americas – Alberta and holds a CA-CPA designation and earned a bachelor’s degree in management from the University of Calgary.

Dr. Peter Facchini, Chief Scientific Officer, has been professor of plant biochemistry in the Department of Biological Sciences at the University of Calgary since 1995. He is recognized internationally as a leader in plant specialized metabolite biosynthesis. Dr. Facchini is the Canada Research Chair in Plant Metabolic Processes Biotechnology and has published more than 150 research papers and scholarly articles. Dr. Facchini received a PhD from the University of Toronto and conducted postdoctoral research at the University of Kentucky and Université de Montréal.

Dr. Joseph Tucker, Executive Chairman of the Board of Directors, holds more than 20 issued or pending patents and is a member of the Board of Directors of BioAlberta. He has extensive senior leadership experience in multiple public and private biotech companies. Dr. Tucker received a PhD in biochemistry and molecular biology from the University of Calgary.

Willow Biosciences Inc. (OTCQB: CANSF), closed Tuesday's trading session at $0.4445, up 1.0227%, on 4,500 volume with 1 trade. The average volume for the last 3 months is 7,809 and the stock's 52-week low/high is $0.400999993/$2.1775.

Recent News

chart

Jerrick Media Holdings, Inc. (OTC: JMDA)

The QualityStocks Daily Newsletter would like to spotlight Jerrick Media Holdings, Inc. (OTC: JMDA).

Jerrick Media Holdings (OTCQB: JMDA), a holding company that gives technology products the resources and opportunities to make ideas a reality, recently published a weekly update from the company’s CEO Jeremy Frommer. To view the full update, visit http://nnw.fm/oc4V6

Jerrick Media Holdings, Inc. (OTC: JMDA) develops technology-based solutions to solve digital problems. Through the combination of design, thought and data analysis, the company builds products that influence a worldwide audience.

Jerrick’s flagship product is Vocal, a proprietary long-form digital publishing platform that provides storytelling tools and engaged communities for creators to get discovered and fund their creativity.

Vocal

Designed to develop and cost-effectively engage content creators, the Vocal platform enables its over 500,000 registered content creators to reach an engaged audience and monetize their content. In addition to providing relevant content, Vocal’s technology is centered on efficiency and scalability through its niche digital communities, as well as output through its data-driven distribution strategy.

Vocal partners with content creators and brands that recognize difficulties inherent in the digital advertising space and that can benefit from branded content marketing opportunities available on publishing platforms like Vocal.

All content available on Vocal is created within the platform’s custom editor and published on one of Vocal’s embedded genre-specific communities, spanning topics that range from food to wellness, beauty, technology and more.

In May 2019, Jerrick launched Vocal+, its premium subscription membership program. Vocal+ members pay a membership fee for premium value-added features, including receiving increased earnings for their content, reduced platform processing fees for tips received, a Vocal+ badge on their creator page, access to new features on the Vocal Platform, and other rewards. Creators can sign up for free or upgrade to Vocal+, available for purchase on either an annual or monthly subscription basis.

 

Vocal for Brands

Vocal for Brands is an in-house creative studio that generates actionable data from bespoke native advertising campaigns. Vocal for Brands partners with direct-to-consumer (DTC) to create beautiful, campaign-optimized stories on Vocal that build brand affinity, trust and drive results.

Additionally, Jerrick provides a Managed Services offering to business-to-business (B2B) and business-to-consumer (B2C) product and service brands which encompasses a full range of digital marketing and e-commerce solutions. Managed Services includes the setup and ongoing maintenance of clients’ websites, Amazon and Shopify storefronts and listings, social media pages, search engine marketing, and other various tools and sales channels utilized by e-commerce sellers for sales and growth optimization. In addition to partnering with Managed Services clients, the company offers a range of la carte services.

Growth Strategy

Upon the consummation of its anticipated listing on the Nasdaq Capital Market, Jerrick intends to change its official company name to “Creatd, Inc.,” subject to stockholder approval.

This rebranding will initiate Jerrick’s go-forward growth strategy and its plans to expand its offerings and provide technology products and resources for creators to help transform their ideas into reality. The strategic plan is designed to greatly increase Jerrick’s potential market value via a plethora of new revenue streams.

Creatd will focus on a community of creators that number more than 2.5 billion users, for which it will offer democratized, transparent platforms for distribution, sentiment, resources and monetization. The company’s agile development process will rely on a combination of bleeding-edge technology that eliminates barriers and creates efficiencies. Superior design thinking and data analysis will allow Creatd to expand its digital footprint to a global community.

Creatd will partner with a community of technology collaborators and sophisticated investors who collaborate to provide technology solutions for creators, brands and their respective audiences. The company’s solutions, business processes, technology platforms and design theories will lend themselves to application opportunities on a global scale.

History & Management

Jerrick was founded in 2012. Initially a private media company providing online content through a portfolio of brands, Jerrick’s needs quickly outpaced its initial technology and product offering. In 2015, Jerrick partnered with Thinkmill, a premiere, Australia-based product design and development group to create a content management system (CMS) for its brands; that system evolved into the company’s flagship product, Vocal.

Today, Jerrick’s management team is an impressive group of abstract thinkers united by their passion to solve problems. Leading the team are founder and CEO Jeremy Frommer, and Justin Maury, Jerrick’s president and head of product.

Frommer’s career includes two decades in the financial technology industry, working as a hedge fund and portfolio manager, as well as on the sell-side of the financial industry. Frommer started NextGen Trading, a software development company building proprietary equity trading platforms. NextGen was acquired by Carlin Financial Group of which Frommer became CEO. RBC Capital Markets Corporation eventually bought Carlin. At RBC, Frommer was managing director, head of the Global Prime Services group and a member of the RBC Global Equities Operating Committee.

Maury joined Jerrick in 2013, bringing with him 10 years of experience in the creative industry. Since partnering with Frommer to establish Jerrick, Maury led the company’s product development for more than four years. His passion for the creative arts and technology ultimately yielded the vision for Vocal. During the Jerrick’s early formative years, Maury was a driving force in creating the vision, design and architecture for the Vocal platform and managing the oversight of technology development.

Jerrick Media Holdings, Inc. (JMDA), closed Tuesday's trading session at $3.90, even for the day, on 1,000 volume. The average volume for the last 3 months is 1,258 and the stock's 52-week low/high is $1.63999998/$5.00.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) was highlighted today in a publication from Financialnewsmedia.com, examining how “Cannabis is back in Congress.” Just months after the House Judiciary Committee approved the Marijuana Opportunity Reinvestment and Expungement (MORE) Act, cannabis legalization will be the subject of another debate in and Commerce Subcommittee, reports Marijuana Moment.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed Tuesday's trading session at $0.5493, up 0.881543%, on 1,188,628 volume with 403 trades. The average volume for the last 3 months is 1,254,709 and the stock's 52-week low/high is $0.469300001/$4.38000011.

Recent News

chart

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision, today announced that it will be holding its annual investor conference on January 30th, 2020 at the Tel Aviv Stock Exchange (“TASE”) Conference Center in Tel Aviv, Israel. Among other topics, the company will present achievements from 2019, new technological developments, and goals for 2020. For more information and registration, visit www.Foresight-Events.net. To view the full press release, visit http://nnw.fm/hr9ZG.

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed Tuesday's trading session at $1.1734, up 0.816221%, on 34,766 volume with 53 trades. The average volume for the last 3 months is 20,925 and the stock's 52-week low/high is $0.697000026/$2.94000005.

Recent News

chart

Green Hygienics Holdings Inc. (OTC: GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Green Hygienics Holdings Inc. (OTCQB: GRYN), an innovative premium cannabis cultivation and branding enterprise, is pleased to announce that it has secured an investment from La Jolla, California-based investment firm TRITON FUNDS (“TRITON”).

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium hemp cultivation and branding enterprise focused on the cultivation and processing of industrial hemp for the purpose of extracting cannabidiol (CBD). With more than 25 years of experience in agricultural science and innovation, Green Hygienics aims to become one of the largest providers of industrial hemp-derived CBD products on the planet.

Green Hygienics’ business model includes generating revenues from the sale of hemp and premium-grade CBD products, creating trusted global consumer brands, developing valuable intellectual property (IP) and growing rapidly through strategic acquisitions. With direct regard to acquisitions, the company acts as a business accelerator and a vertical integrator supporting rapid growth and development of companies with extraordinary potential.

Innovation – the Future of Commercial Cultivation

The greatest challenge of the cannabis industry is determining how to deliver a safe and premium-quality product on a consistent basis; antiquated production methods are riddled with recalls and are unsafe from a cultivation production standpoint. Green Hygienics’ solution is to employ scientific methodology combined with sustainable farm practices to achieve optimal soil refinement. The company’s objectives are to produce higher yields and a superior product on a consistent basis to always remain compliant through diligent testing. A secure, premium-quality supply chain is the foundation for the company’s operations.

Green Hygienics’ cultivation approach is based on scientific measurements and data analysis, which transform the cultivation environment into a laboratory environment to deliver superior product.

State-of-the-Art Processing

Processing hemp to produce the finest-quality CBD is a complex, multistage process that should be performed with adherence to the highest standards. Once harvested, the hemp must be carefully handled, dried and stored to prepare it for CBD extraction. Each and every step must be given full care and attention. Green Hygienics’ ambition is to create state-of-the-art infrastructure, employ the latest large-scale processing technologies and adhere to strict quality management systems.

The company strives to constantly develop innovations in industrial hemp for CBD cultivation and to create solutions that lower costs, deliver higher yields and address the challenges of large-scale production.

Brand Development, Marketing and Direct Sales

One of the core drivers of the Green Hygienics business model is to develop or acquire unique brands with global distribution potential. The company sees the market becoming increasingly competitive, and establishing Green Hygienics’ own distinct, trusted brands will be important. By controlling its own supply chain, the company can also leverage strategic advantages in the marketplace, such as the ability to deliver a “best in class” product on a consistent basis. Successful branding is demonstrated by a positive response to a company’s customer service, reputation and products, and Green Hygienics Holdings is acutely aware of the value in this.

Ahead of the Curve

The clear competitive advantage Green Hygienics holds over industry peers is cultivating premium product within the upper-scale product category more efficiently than anyone else in the industry. Currently, the average-size hemp farm in North America is 9 acres. Green Hygienics addresses the challenge of scalability through its farming methodology.

The company’s objective is to produce a higher quality of product at a lower cost and to deliver the finest-quality product to consumers without exception.

In today’s market, inefficient companies and those that produce an inferior product will become vulnerable or disappear, adding considerable value to companies like Green Hygienics that efficiently innovate and operate. The premium cannabis market will continue to achieve higher pricing, and the demand will stabilize. At the end of the day, successful branding backed by superior product will cause companies like Green Hygienics to rise above the competition.

Outlook

Companies within the cannabis sector, states and lawmakers are still figuring out how legislation, consumer demand and innovations will shape the industry. As a safeguard and for long-term resilience, Green Hygienics is preparing for the next plateau with proprietary cultivation and processing systems and tightly controlled growth environments that enable containment of production costs, delivery of higher yields and production of a premium product. These margins will provide the company with a strategic advantage within an increasingly competitive marketplace.

Green Hygienics is constantly studying the market dynamics in North America and abroad and anticipates that both the domestic and international markets will appreciate and be willing to pay a premium to those companies that can deliver best-in-class products.

In line with this expectation, the company’s additional objectives are to secure investment, enhance its balance sheet and increase its value through profitable operations as well as through acquiring and owning the real estate or land it builds upon. Over the long term, this will help Green Hygienics grow in value, provide leverage for rapid expansion and offer security for investors. The company will be positioned to capitalize on any opportunity within the industry or to acquire distressed assets, which is part of its growth strategy.

Green Hygienics plans to establish lead brands starting in the California market, to secure trademarks, and to develop and secure intellectual property assets with regard to cultivation and processing.

Green Hygienics Holdings Inc. (GRYN), closed Tuesday's trading session at $1.93, up 0.862294%, on 20,779 volume with 40 trades. The average volume for the last 3 months is 9,326 and the stock's 52-week low/high is $0.310000002/$2.48000001.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.